Clinical Trials
596
Active:4
Completed:205
Trial Phases
4 Phases
Phase 2:19
Phase 3:31
Phase 4:4
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (400 trials with phase data)• Click on a phase to view related trials
Not Applicable
341 (85.3%)Phase 3
31 (7.8%)Phase 2
19 (4.8%)phase_2_3
5 (1.3%)Phase 4
4 (1.0%)Vitamin C for Acute Kidney Injury in ACLF With Septic Shock: A Randomized Controlled Trial
Not Applicable
Not yet recruiting
- Conditions
- Acute-on-Chronic Liver Failure (ACLF)
- Interventions
- Other: Standard of Care (SOC)
- First Posted Date
- 2025-09-22
- Last Posted Date
- 2025-09-22
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 110
- Registration Number
- NCT07184866
Double Plasma Separation and Adsorption in Acute-on-Chronic Liver Failure (DPMAS-ACLF Trial)
Not Applicable
Not yet recruiting
- Conditions
- Acute-on-Chronic Liver Failure (ACLF)
- First Posted Date
- 2025-09-17
- Last Posted Date
- 2025-09-24
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 56
- Registration Number
- NCT07178366
National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Phase I Study on Safety and Efficacy of Mesenchymal Stem-Cell (MSC) Therapy in Non-Viral Acute-on-Chronic Liver Failure (ACLF)
Not Applicable
Not yet recruiting
- Conditions
- Acute-On-Chronic Liver Failure
- Interventions
- First Posted Date
- 2025-08-20
- Last Posted Date
- 2025-08-28
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 10
- Registration Number
- NCT07131540
National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Single vs Repeated Cycle of Granulocyte Colony-Stimulating Factor (GCSF) & Darbepoetin in Early Decompensated Cirrhosis
Not Applicable
Not yet recruiting
- Conditions
- Decompensated Cirrhosis
- Interventions
- First Posted Date
- 2025-08-20
- Last Posted Date
- 2025-08-20
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 110
- Registration Number
- NCT07131280
- Locations
- 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, India
National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem Cell Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patient- Phase-II Trial
Not Applicable
Not yet recruiting
- Conditions
- Acute-On-Chronic Liver Failure
- Interventions
- Drug: ucMSC and Standard medical treatmentOther: Standard medical treatment
- First Posted Date
- 2025-08-20
- Last Posted Date
- 2025-08-20
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 100
- Registration Number
- NCT07131306
- Locations
- 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India
- Prev
- 1
- 2
- 3
- 4
- 5
- 58
- Next
News
No news found